Moderna Receives Medicines and Healthcare Products Regulatory Agency Marketing Authorization in the UK for RSV Vaccine

Contributed by: ACCESS Newswire

Logo

Tags

Healthcare & Pharmaceutical

Moderna, Inc.

NASDAQ:MRNA

Company Update

More Like This

Moderna Receives European Commission Approval for RSV Vaccine mRESVIA(R)

EMA Committee For Medicinal Products For Human Use Adopts Positive Opinion Recommending Marketing Authorization Of Moderna’s RSV Vaccine, mRESVIA(R)

Moderna Announces Global Regulatory Submissions For Its Respiratory Syncytial Virus (RSV) Vaccine, MRNA-1345

Moderna to Showcase Extensive Infectious Disease Research at ESCMID 2025

EMA Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Authorization of Moderna's COVID-19 mRNA Vaccine Targeting the SARS-COV-2 Variant JN.1

National RSV vaccination programme announced

New RSV vaccine could prevent 5,000 infant hospitalisations

EMA Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Authorization of Moderna’s Updated Covid-19 Vaccine in The European Union